| Name | Title | Contact Details |
|---|
Alliance Physical Therapy Partners is the 7th largest physical therapy provider in the U.S., with more than 70 outpatient PT locations nationwide. The company was founded by patient-focused healthcare experts who were seeking to transform the traditional healthcare experience by infusing innovation and passion so that more people can enjoy the benefits of physical therapy. Alliance Physical Therapy Partners is also the parent company of Work-Fit, an injury prevention solutions provider who applies sports medicine techniques in the workplace to prevent injuries. In addition, BioCorrect Custom Orthotics Lab is part of the Alliance Physical Therapy Partner brands, providing a patented foot alignment system, evaluation process, and innovative custom and semi-custom foot orthotics for competitive athletics, outdoor recreation or people just living life to the fullest. Alliance Physical Therapy Partners is an affiliate of GPB Capital Holdings, LLC focused on acquiring private physical therapy practices across the U.S. to provide practice owners the opportunity to expand their footprint while receiving operational guidance and financial support. The Alliance team includes former private practice owners, direct marketing professionals and operations experts who have experience running and growing successful healthcare organizations. About GPB Capital Holdings, LLC GPB Capital is a New York-based alternative asset management firm focusing on acquiring income-producing private companies. GPB Capital seeks to provide its portfolio companies with the strategic planning, managerial insight, and capital needed to enable strong businesses to achieve the next level of growth and profitability. GPB Capital has over $1.5 billion in assets under management[i] and has acquired or invested in more than 160 portfolio companies. For more information, please visit www.gpb-cap.com. [i] Which is different and distinct from GPB Capital`s “Regulatory AUM.”
Founded in 1943, Heartland Blood Centers' mission is to provide and maintain an adequate supply of blood and blood products for area hospitals to draw upon to meet the needs of patients.
Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team`s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies.
iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias. We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.
Intrexon Corporation (NYSE: XON) is a leader in synthetic biology focused on collaborating with companies in Health, Food, Energy, Environment, and Consumer Sectors to create biologically-based products that improve the quality of life and the health of the planet. Through the company’s proprietary UltraVector® platform and and suite of technologies, Intrexon provides its partners with industrial-scale design and development of complex biological systems. The UltraVector® platform delivers unprecedented control over the quality, function, and performance of living cells. We call our synthetic biology approach and integrated technologies Better DNA®, and we invite you to discover more at www.DNA.com.